CPA1 and infection: Infection prevalence was also significantly reduced, from 98.1% in WT to 57.7% (a 1.7-fold reduction) in CpA-Dcr2 and 65.4% (a 1.5-fold reduction) in CpA-R2d2 transgenic mosquitoes (Fig 2D, Fisher’s exact test, ****P < 0.0001).